DPP-4 inhibitors for the treatment of type 2 diabetes: a methodology overview of systematic reviews.
Ling Juan, Ge Long, Zhang Ding-Hua, +5 more·Acta diabetologica
AIMS: To evaluate the methodological quality of systematic reviews (SRs), and summarize evidence of important outcomes from dipeptidyl peptidase-4 inhibitors (DPP4-I) in treating type 2 diabetes mellitus (T2DM). METHODS: We included SRs of DPP4-I for the treatment of T2DM until January, 2018 by searching the Cochrane…